Clearside Biomedical to Participate in Multiple Upcoming Investor and Ophthalmology Conferences in November and December 2022

Rhea-AI Summary

Clearside Biomedical (NASDAQ:CLSD) has announced its participation in several key conferences this November and December 2022. The events include:

• BTIG Ophthalmology Day on November 29 at 10:30 a.m. ET
• Piper Sandler 34th Annual Healthcare Conference on December 1 at 9:50 a.m. ET
• Ophthalmology Innovation Summit on December 3
• Cantor MedTech Conference on December 8 at 2:45 p.m. ET

Webcasts will be available on the Clearside website under the Investors section, showcasing the company's innovative SCS Microinjector platform for targeted eye therapy delivery.

ALPHARETTA, Ga., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS^®), announced today that management will participate in the following conferences in November and December 2022:

BTIG Ophthalmology Day
Fireside Chat
Tuesday, November 29, 2022 at 10:30 a.m. ET

Piper Sandler 34th Annual Healthcare Conference
Corporate Presentation
Thursday, December 1, 2022 at 9:50 a.m. ET

Ophthalmology Innovation Summit (OIS) XII
Panel Discussion: Spotlight on Gene & Cell Therapy
Retina Innovation Showcase: Corporate Presentation
Saturday, December 3, 2022

Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
Ophthalmology Panel Discussion: Take A Look At What's In Store For Wet AMD & Related Diabetic Eye Diseases
Thursday, December 8, 2022 at 2:45 p.m. ET

A link to the live and archived webcasts may be accessed on the Clearside website under the Investors section: Events and Presentations.

About Clearside Biomedical

Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS^®). Clearside’s SCS injection platform, utilizing the Company’s proprietary SCS Microinjector^®, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector and strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. Clearside’s first product, XIPERE^® (triamcinolone acetonide injectable suspension) for suprachoroidal use, is commercially available in the U.S. For more information, please visit www.clearsidebio.com.

Investor and Media Contacts:

Jenny Kobin
Remy Bernarda
ir@clearsidebio.com
(678) 430-8206

Source: Clearside Biomedical, Inc.

FAQ

What conferences is Clearside Biomedical attending in November and December 2022?

Clearside Biomedical will attend the BTIG Ophthalmology Day on November 29, Piper Sandler 34th Annual Healthcare Conference on December 1, Ophthalmology Innovation Summit on December 3, and Cantor MedTech Conference on December 8, 2022.

When is the BTIG Ophthalmology Day for Clearside Biomedical?

The BTIG Ophthalmology Day is scheduled for November 29, 2022, at 10:30 a.m. ET.

What is the date for the Piper Sandler 34th Annual Healthcare Conference participation by Clearside Biomedical?

Clearside Biomedical will participate in the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022, at 9:50 a.m. ET.

When will Clearside Biomedical present at the Ophthalmology Innovation Summit?

Clearside Biomedical will present at the Ophthalmology Innovation Summit on December 3, 2022.

What is the focus of the Cantor MedTech Conference where Clearside Biomedical will participate?

The Cantor MedTech Conference will feature a panel discussion on December 8, 2022, focused on Wet AMD and related diabetic eye diseases.